Crystalline versus non-crystalline light-chain proximal tubulopathy: a case series.
- 1Department of Pathology, QingPu Branch, Zhongshan Hospital Affiliated to Fudan University, Shanghai, China.
- 2Department of Pathology, Zhongshan Hospital (Xiamen Branch), Fudan University; Clinical Research Center for Precision Medicine of Abdominal Tumor of Fujian Province, Xiamen, China.
- 3Department of Pathology, School of Basic Medical Sciences, Fudan University, Shanghai, China.
Abstract
Light-chain proximal tubulopathy (LCPT) represents a rare paraprotein-associated kidney disorder resulting from the intracellular accumulation of monoclonal free light chains within proximal tubular epithelial cells, and manifests as either crystalline or non-crystalline inclusions. Crystalline LCPT is most frequently observed in IgG-κ multiple myeloma. Conversely, IgD-λ multiple myeloma typically presents as the non-crystalline variant. The histopathological findings, clinical correlations, and therapeutic outcomes differ substantially between these two entities. This study comparatively analyzed two LCPT cases and summarized the clinicopathological characteristics, diagnostic strategies and treatment outcomes of different LCPT subtypes. The 55-year-old male patient with IgG-κ multiple myeloma presented with renal insufficiency, and renal biopsy confirmed crystalline LCPT. Typical crystalline structures in proximal tubular epithelial cells and κ light chain deposition were verified by light, electron and immunoelectron microscopy. The patient achieved favorable hematologic and renal prognosis after bortezomib-based chemotherapy combined with autologous hematopoietic stem-cell transplantation (ASCT). The 64-year-old male patient with IgD-λ multiple myeloma suffered from progressive renal failure. Biopsy revealed non-crystalline LCPT characterized by non-crystalline lysosomal lesions with concurrent light-chain cast nephropathy, characterized by non-crystalline lysosomal lesions and λ light chain accumulation. He received multiple cycles of bortezomib-based chemotherapy without ASCT and finally died of multiple organ failure. Literature review indicates that LCPT morphological phenotypes are closely correlated with light chain subtypes. IgD-λ-related non-crystalline LCPT is rarer, more aggressive, and prone to severe renal impairment. In conclusion, for patients with unexplained proximal tubular dysfunction and monoclonal gammopathy, early precise diagnosis relying on ultrastructural examination and light chain immunohistochemical detection is critical. Bortezomib combined with ASCT is the optimal treatment for LCPT to achieve hematologic remission and preserve renal function, while close attention is required for high-risk IgD-λ non-crystalline LCPT.
Related
- Cathepsin resistance mediated by key amino acid substitutions drives intracellular crystallization in light chain proximal tubulopathy
- Femoral allograft augmentation in addition to locking plate fixation in displaced proximal humerus fractures: a retrospective case-series
- Matrix-preserving partial nail resection guided by a spike-like proximal nail plate for ingrown toenails: A 2-center retrospective case series
- Safety and efficacy of strictureplasty for primary proximal duodenal Crohn’s disease: a retrospective single-center case series
- Time-driven activity-based costing comparison of intramedullary nails versus locking plates for proximal humerus fractures: what is the primary cost driver?
BibTeX
@article{zhang2026crystalline,
title = {{Crystalline versus non-crystalline light-chain proximal tubulopathy: a case series.}},
author = {Zhi-Rong Zhang and Li-Mei Wang and Xiao-Le Meng and Ting Zhu and Zhi-Gang Zhang and Zhong-Hua Zhao and Wei-Xia Wang and Si-Nian Huang},
journal = {Frontiers in medicine},
year = {2026},
month = oct,
doi = {10.3389/fmed.2026.1963349},
url = {https://europepmc.org/article/MED/42952746},
note = {CC BY},
}
RIS
TY - JOUR
TI - Crystalline versus non-crystalline light-chain proximal tubulopathy: a case series.
AU - Zhi-Rong Zhang
AU - Li-Mei Wang
AU - Xiao-Le Meng
AU - Ting Zhu
AU - Zhi-Gang Zhang
AU - Zhong-Hua Zhao
AU - Wei-Xia Wang
AU - Si-Nian Huang
PY - 2026
DA - 2026/10/14
JO - Frontiers in medicine
DO - 10.3389/fmed.2026.1963349
UR - https://europepmc.org/article/MED/42952746
AB - Light-chain proximal tubulopathy (LCPT) represents a rare paraprotein-associated kidney disorder resulting from the intracellular accumulation of monoclonal free light chains within proximal tubular epithelial cells, and manifests as either crystalline or non-crystalline inclusions. Crystalline LCPT is most frequently observed in IgG-κ multiple myeloma. Conversely, IgD-λ multiple myeloma typically presents as the non-crystalline variant. The histopathological findings, clinical correlations, and therapeutic outcomes differ substantially between these two entities. This study comparatively analyzed two LCPT cases and summarized the clinicopathological characteristics, diagnostic strategies and treatment outcomes of different LCPT subtypes. The 55-year-old male patient with IgG-κ multiple myeloma presented with renal insufficiency, and renal biopsy confirmed crystalline LCPT. Typical crystalline structures in proximal tubular epithelial cells and κ light chain deposition were verified by light, electron and immunoelectron microscopy. The patient achieved favorable hematologic and renal prognosis after bortezomib-based chemotherapy combined with autologous hematopoietic stem-cell transplantation (ASCT). The 64-year-old male patient with IgD-λ multiple myeloma suffered from progressive renal failure. Biopsy revealed non-crystalline LCPT characterized by non-crystalline lysosomal lesions with concurrent light-chain cast nephropathy, characterized by non-crystalline lysosomal lesions and λ light chain accumulation. He received multiple cycles of bortezomib-based chemotherapy without ASCT and finally died of multiple organ failure. Literature review indicates that LCPT morphological phenotypes are closely correlated with light chain subtypes. IgD-λ-related non-crystalline LCPT is rarer, more aggressive, and prone to severe renal impairment. In conclusion, for patients with unexplained proximal tubular dysfunction and monoclonal gammopathy, early precise diagnosis relying on ultrastructural examination and light chain immunohistochemical detection is critical. Bortezomib combined with ASCT is the optimal treatment for LCPT to achieve hematologic remission and preserve renal function, while close attention is required for high-risk IgD-λ non-crystalline LCPT.
SN - 2296-858X
ER -